Abbott Declares 399th Consecutive Quarterly Dividend


Werte in diesem Artikel
Aktien

82.14 EUR 0.00 EUR 0.0 %

ABBOTT PARK, Ill., Sept. 21, 2023 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share.

This marks the 399th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2023, to shareholders of record at the close of business on Oct. 13, 2023.

Abbott has increased its dividend payout for 51 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

Cision View original content:https://www.prnewswire.com/news-releases/abbott-declares-399th-consecutive-quarterly-dividend-301935213.html

SOURCE Abbott

Aktuelle Abbott Laboratories Aktie News

Werbung

Abbott Laboratories Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Abbott Laboratories nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.08.20 Abbott Laboratories Sell Goldman Sachs Group Inc.
16.10.18 Abbott Laboratories Overweight Barclays Capital
25.01.18 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.
15.12.17 Abbott Laboratories Outperform BMO Capital Markets
19.10.17 Abbott Laboratories Buy Stifel, Nicolaus & Co., Inc.